Home/Filings/4/0000899243-22-025833
4//SEC Filing

EW HEALTHCARE PARTNERS FUND 2-A, L.P. 4

Accession 0000899243-22-025833

CIK 0001561921other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 5:58 PM ET

Size

15.6 KB

Accession

0000899243-22-025833

Insider Transaction Report

Form 4
Period: 2022-07-06
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-06$7.86/sh+5,000$39,3003,580,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-08$7.96/sh+5,000$39,8003,590,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-07$8.07/sh+5,000$40,3503,585,709 total(indirect: See footnotes)
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-06$7.86/sh+5,000$39,3003,580,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-07$8.07/sh+5,000$40,3503,585,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-08$7.96/sh+5,000$39,8003,590,709 total(indirect: See footnotes)
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-06$7.86/sh+5,000$39,3003,580,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-08$7.96/sh+5,000$39,8003,590,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-07$8.07/sh+5,000$40,3503,585,709 total(indirect: See footnotes)
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-06$7.86/sh+5,000$39,3003,580,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-08$7.96/sh+5,000$39,8003,590,709 total(indirect: See footnotes)
  • Purchase

    Common Stock, par value $0.001 per share

    2022-07-07$8.07/sh+5,000$40,3503,585,709 total(indirect: See footnotes)
Footnotes (2)
  • [F1]The Share totals shown above are the aggregate amounts of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the dates set forth above. Fund 2 purchased 1,500 shares of the amount shown for each date above, and Fund 2-A purchased 3,500 shares of the amount shown above on each such date. Fund 2 now holds a total of 1,430,011 shares and Fund 2-A now holds a total of 2,160,698 shares of the Issuer.
  • [F2]EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P . ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims ownership over the Shares except to the extent of his or its respective pecuniary interest therein.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001746779

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 5:58 PM ET
Size
15.6 KB